companydata.dkcompanydata.dk

PHARMAVEST ApS: Financial statements 2019

CVR: 26385180

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,771,479 and a net result of DKK 817,782 compared with DKK 360,195 the year before. That is an increase of 63.2% compared with the year before. Equity in the 2019 report amounted to DKK 3,642,522. The solvency ratio was 84.3%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,771,479
Profit/Loss
DKK 817,782
Equity
DKK 3,642,522
Total Assets
DKK 4,318,933
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.8 mio.818 t.3.6 mio.1
2018-1.1 mio.360 t.2.9 mio.1
2017-338 t.-261 t.2.6 mio.1
2016-479 t.-94 t.2.8 mio.1
2015-822 t.57 t.2.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

PHARMAVEST ApS: The 2018 annual report is outMay 22, 2019

PHARMAVEST ApS has published its annual report for 2018. Gross profit came to DKK 1,085,349, and the net result was DKK 360,195.

About PHARMAVEST ApS

PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.

Source: annual report 2025, Danish Business Authority